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Cleavage of Chordin by Xolloid Metalloprotease
Suggests a Role for Proteolytic Processing in
the Regulation of Spemann Organizer Activity
function of Chordin is to inhibit ventralizing signals
(Hammerschmidt et al., 1996b).
Chordin is a homolog of the protein encoded by the
Drosophila short-gastrulation (sog) gene, sharing both
structural (FrancË ois and Bier, 1995) and functional (Hol-
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University of California ley et al., 1995) properties. Because sog is expressed
ventrally in Drosophila and chordin dorsally in vertebrates,Los Angeles, California 90095-1662
²Department of Anatomy and Developmental this finding has lent support to the hypothesis of E. Geoff-
roy Saint-Hilaire that an inversion of the dorsal-ventralBiology
University College London axis occurred during the course of animal evolution (re-
viewed by De Robertis and Sasai, 1996). In genetic stud-London, WC1E 6BT
United Kingdom ies, sog functions as an inhibitor of decapentaplegic
(dpp) (Ferguson and Anderson, 1992a). DPP is the main
zygotic dorsoventral morphogen in Drosophila (Fergu-
son and Anderson, 1992b; Wharton et al., 1993) andSummary
is functionally homologous to vertebrate BMP-2 and
BMP-4 (Padgett et al., 1993). As is the case for swirlThe Xolloid secreted metalloprotease, a tolloid-related
and chordino, dpp is epistatic to sog in double mutantsprotein, was found to cleave Chordin and Chordin/
(Biehs et al., 1996; Holley et al., 1996), suggesting thatBMP-4 complexes at two specific sites in biochemical
sog is a dedicated antagonist of dpp.experiments. Xolloid mRNA blocks secondary axes
dpp also interacts genetically with tolloid (tld), but thiscaused by chordin, but not by noggin, follistatin, or
interaction has opposite effects to those of sog, sincedominant-negative BMP receptor, mRNA injection.
tolloid is required to increase the activity of dpp (Fergu-Xolloid-treated Chordin protein was unable to antago-
son and Anderson, 1992a). Many tld alleles areavailable,nize BMP activity. Furthermore, Xolloid digestion re-
forming an unusually rich allelic complementation seriesleased biologically active BMPs from Chordin/BMP
and, interestingly, about a third of them are antimorphsinactive complexes. Injection of dominant-negative
that are thought to act as dominant inhibitors of tldXolloid mRNA indicated that the in vivo function of
activity (JuÈ rgens et al., 1984; Ferguson and Anderson,Xolloid is to limit the extent of Spemann's organizer
1992a; Childs and O'Connor, 1994; Finelli et al., 1994).field. We propose that Xolloid regulates organizer
tolloid encodes a secreted metalloprotease of the as-function by a novel proteolytic mechanism involving
tacin family that contains in its carboxy-terminal portiona double inhibition pathway required to pattern the
an extended interaction domain. This domain is com-dorsoventral axis:
posed of two EGF repeats and five repeats similar to
XOLL ¢ CHD ¢ BMPs → BMPR those found in the protein±protein interaction domains
of the serum complement proteins C1r and C1s (Shimell
et al., 1991).
Introduction The structure of tolloid is related to that of BMP-1, a
metalloprotease isolated from demineralized bone ex-
Recent advances on the molecular mechanisms by tracts that purified together with the TGFb superfamily
which the dorsal lip of the gastrula induces neuralization members BMP-2 and BMP-3 (Wozney et al., 1988). The
of ectoderm and dorsalization of mesoderm have re- copurification suggested that BMP-1 and BMP-2 might
vealed that the organizer secretes proteins that inhibit physically interact, leading to the idea that Tolloid might
ventral signals (reviewed by Graff, 1997; Hemmati-Bri- increase DPP activity by proteolytically processing DPP
vanlou and Melton, 1997; Moon et al., 1997). Three of precursors (Shimell et al., 1991; Childs and O'Connor,
these proteins, Chordin, Noggin, and Follistatin, bind to 1994; Finelli et al., 1994). However, the finding that the
ventral BMP signals in the extracellular space, blocking sog homolog chordin formed an inactive complex with
the interaction of BMPs with their receptors (Piccolo et BMPs with high specificity (Piccolo et al., 1996) sug-
al., 1996; Zimmermann et al., 1996; Fainsod et al., 1997). gested an alternative possibility. Holley et al. (1996) pro-
The role of Chordin in this antagonistic model of orga- posed that the Tolloidprotease might cleave a hypothet-
nizer function has recently received geneticsupport with ical complex of SOG and DPP, releasing active DPP
the finding that the ventralizing chordino mutation in from an inactive complex. In other words, the activation
zebrafish encodes a null allele of chordin (Hammer- of DPP activity by TLD could result from a double inhibi-
schmidt et al., 1996a; Schulte-Merker et al., 1997). In tion mechanism by which:
genetic analyses, chordino interacts with the dorsalizing
TLD ¢ SOG ¢ DPPswirl mutation, which is thought to encode a BMP-like
activity. Double chordino2/2; swirl2/2 mutants display a
This molecular mechanism can be tested biochemi-swirl dorsalized phenotype, suggesting that the sole
cally. The availability of active Chordin protein and of
recombinant BMPs of Xenopus origin (Hazama et al.,
1995; Piccolo et al., 1996) led us to test whether a similar³To whom correspondence should be addressed.
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mechanism exists in Xenopus and has been conserved Results
for regulating the activity of Chordin in the Spemann
Xolloid mRNA Ventralizes Ectoderm and Mesodermorganizer. For this purpose, we used a Xenopus tolloid-
To test the hypothesis that Xolloid might inactivatelike gene called Xolloid (Goodman et al., 1997). Xolloid
Chordin, we first investigated whether Xolloid microin-was chosen because, like BMP-4, it has a strong ven-
jection could mimic the effects of chordino loss-of-func-tralizing activity in Xenopus animal cap explants, in
tion in zebrafish. Xolloid mRNA was injected into fourwhich it is able to override the dorsalizing effects of
blastomeres at the 4- or 8-cell stage (radial injections)activin, leading to the formation of blood and ventral
of Xenopus development, and the resulting embryosmesoderm, as BMP-4 does (Dale et al., 1992; Jones et
were analyzed by whole-mount in situ hybridization. Atal., 1992; Goodman et al., 1997). In the Xenopus embryo,
the gastrula/neurula stage, a considerable reduction ofXolloid mRNA accumulates in oocytes and unfertilized
the neural domain (marked by Sox-2 and Slug) was ob-eggs, and levels are maintained through early develop-
served in the ectoderm (Figures 1A and 1B). Markersment until the start of neurulation (Goodman et al., 1997).
of dorsal mesoderm were also reduced by injection ofAt these stages, the Xenopus embryo also expresses
Xolloid (sonic hedgehog and MyoD, Figures 1C and 1D),significant amounts of BMP-2, BMP-4, and BMP-7 (Dale
while a ventral mesodermal marker was expandedet al., 1992; Nishimatsu et al., 1992; Hemmati-Brivanlou
(Xwnt-8, Figure 1F). Despite the strong ventralizationand Thomsen, 1995). Therefore, Xolloid and BMPs are
revealed by these early markers, by the swimming tad-coexpressed during early development. Although Xol-
pole stage (3 days) similarly injected embryos recoveredloid transcripts appear to be uniformly distributed at
to a considerable extent (Figure 1I). However, these tad-these early stages, at the tailbud stage Xolloid tran-
poles still had reduced heads and CNS, the notochordscripts are found in the tail periphery surrounding the
was frequently absent, somites were reduced, and con-chordin-expressing cells of the chordoneural hinge
comitantly, an increased amount of ventral blood islands(B. L., unpublished data). Thus, Xolloid is expressed at
were observed in histological sections (data not shown).the right time in development to possibly interact with
This recovery of axial structures was reminiscent ofChordin and BMPs.
the case of the chordino mutation in zebrafish, whichThe overall structure of Xolloid is very similar to that
has severe reductions of dorsal ectodermal and meso-of tolloid, with a metalloprotease domain followed by
dermal markers at the gastrula stage but undergoesan interaction domain composed of two EGF and five
a remarkable recovery by the end of embryogenesisC1r/s repeats. In the mouse, two related genes have
(Hammerschmidt et al., 1996a, 1996b). In addition, inbeen isolated, tolloid-like (mtll) and mBMP-1. mtll has
chordino mutants, expression of BMP-4 is increasedan overall structure similar to that of Xolloid and tolloid
(Hammerschmidt et al., 1996b) and, although chordino(Takahara et al., 1996), although it is unclear at present
mRNA is initially expressed normally, its transcriptionwhether it is a Xolloid homolog. A similar structure is
collapses in the organizer at mid-gastrula stages (Schulte-also found in a spliced form of BMP-1, while a shorter
Merker et al., 1997). Thus, the loss of Chordin-BMPform lacks one EGF and two C1r/s repeats. Both forms
antagonism in the extracellular space is potentiated byhave been shown to process the C terminus of fibrillar
a feedback loop that leads to activation of BMP trans-procollagens (Kessler et al., 1996). In contrast to Xolloid,
cription and repression of chordino transcription (Schulte-the short-form of Xenopus BMP-1 is unable to mimic
Merker et al., 1997). Interestingly, radial Xolloid mRNAthe blood-inducing activity of BMP-4 in activin-treated
injections result in a similar expansion of BMP-4 expres-animal caps (Goodman et al., 1997; MaeÂ no et al., 1993),
sion (Figure 1F) and in the lackof maintenance of chordinand the long form is reported to dorsalize ventral meso-
expression at mid-gastrula stages (compare Figures 1Gderm (Lin et al., 1997). Taken together, the biological
and 1H).activity in animal caps, the expression in the early em-
These results indicate that overexpression of the Xol-
bryo, and the structural similarities suggested that Xol-
loid secreted protease results in the loss of dorsal ecto-
loid was the best candidate to mediate a tolloid-like
dermal and mesodermal tissues at the gastrula stage.
activity in Xenopus.
The similarities with the zebrafish chordino mutant sug-
In this study, we present data showing that in mRNA gest that the effect of Xolloid overexpression in Xenopus
microinjection assays, Xolloid acts upstream of BMP is to partially antagonize the dorsalizing role of organizer
receptor signaling, blocking the effects of chordin but signals.
not those of noggin or follistatin. In biochemical studies,
soluble Xolloid protein has protease activity, cleaving
chordin at two specific sites and inactivating its BMP Xolloid Inactivates Chordin
antagonizing activity. Digestion of an inactive complex Ventralization by Xolloid mimics the effects of injection
of BMPs and Chordin with Xolloid results in the recovery of low doses of BMP-4 (Dale et al., 1992; Jones et al.,
of BMP biological activity. Experiments with a dominant- 1992). To test whether Xolloid functions through the
negative point mutation in Xolloid indicate that the Xol- BMP pathway, Xolloid mRNA was injected together with
loid protease activity is required in vivo for correct dor- a dominant-negative BMP receptor (DNBMPR) that mim-
soventral patterning in Xenopus. Taken together, the ics organizer activity, causing the formation of second-
results suggest a novel mechanism for regulating the ary axes after microinjection into ventral blastomeres at
activity of Spemann's organizer mediated by a proteo- the 4-cell stage (Graff et al., 1994; Suzuki et al., 1994).
Xolloid mRNA had no effect on these secondary dorsallytic step.
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Figure 2. Xolloid Acts Upstream of BMP Receptor and Blocks Sec-
ondary Axes Induced by chordin but Not by noggin or follistatin
(A) Double axes and dorsalized embryos induced by injection of 150
pg of DNBMPR mRNA (67%, n 5 57).
(B) Double axes and dorsalized embryos induced by coinjection of
150 pg of DNBMPR with 400 pg of XLD mRNA (62%, n 5 53).
(C) Secondary axes induced by injection of 100 pg of chd (69%,
n 5 71).Figure 1. Xolloid (XLD) Ventralizes Ectoderm and Mesoderm
(D) XLD mRNA (400 pg) negates the activity of 100 pg of CHD mRNA
(A±H) Ventralization of ectoderm and mesoderm revealed by whole-
(2%, n 5 128).
mount in situ hybridization. Uninjected (left) and XLDmRNA±injected
(E) Coinjection of 20 pg of noggin mRNA with 400 pg of XLD mRNA
embryos (right) were probed for the indicated markers. Injections
results in secondary axis induction (57%, n 5 75) at a similar fre-were done radially with 200 ng of XLD mRNA per blastomere at the
quency as 20 pg of noggin mRNA alone (48%, n 5 55, data not8-cell stage in the animal cap (A and B) or in the marginal zone
shown).(C±H). (A-D) Neurula stage embryos stained for (A) the neural marker
(F) Coinjection of 150 pg of follistatin mRNA with 400 pg of XLDSox-2, (B) the neural crest marker slug, (C) the dorsal mesoderm
mRNA results in secondary axis induction (61%, n 5 32) at a similarand floor plate marker Shh, and (D) the dorsal mesoderm marker
frequency as 150 pg of follistatin mRNA alone (64%, n 5 40, dataMyoD. Note the reduction of the neural and dorsal mesodermal
not shown). All embryos were injected in a ventral blastomere atfields. (E) At midgastrula stages, the ventrolateral marker Xwnt8 is
the 4-cell stage. Note that Xolloid specifically blocks the activity of
expanded and expressed in the organizer in Xld-injected embryos.
chordin.
(F) At neurula stages, the BMP-4 domain is expanded in Xld-injected
embryos, reducing the size of the neural plate. (G and H) Chd at early
and late gastrula stages, respectively. Note that the transcription of sequestering BMPs in the extracellular space, leading to
Chd in Xld-injected embryos starts normally but collapses during
the formation of secondary axes. Xolloid mRNA wasthe course of gastrulation.
found to block secondary axis induction by chordin(I) Normal (top) and XLD-injected 3-day tadpoles (bottom). Embryos
mRNA (compare Figures 2C and 2D), but had no effectwere injected radially with 200 pg of XLD mRNA in each blastomere
at the 4-cell stage. Note the recovery to a relatively mild ventraliza- on secondary axes induced by noggin or follistatin (Fig-
tion (93% affected, DAI 5 3.2, n 5 311) when compared with the ures 2E and 2F). The observation that Xolloid is specific
severe reduction in axial and neural markers observed at the early for chordin is of particular importance regarding the
stages.
sequence similarities found between Xolloid and BMP-1.
Mammalian BMP-1 is a procollagen processing prote-
ase (Kessler et al., 1996; Suzuki et al., 1996), and a caseaxes, indicating that Xolloid requires an active BMP path-
way to exert its ventralizing activity (Figures 2A and 2B). could have beenmade for the ventralizingeffectsof Xolloid
being mediated by proteolytic modifications of the extra-Three dorsalizing factors, Chordin, Noggin, and Fol-
listatin, have been shown to inhibit the BMP pathway by cellular matrix. Because noggin, follistatin, or DNBMPR
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secondary axes were not affected by Xolloid injection,
and because a dominant-negative Xolloid construct dor-
salized the embryo (see below), the ventralizing effect
cannot be due to nonspecific changes in the matrix.
Although one cannot exclude the existence of addi-
tional, as yet undiscovered, substrates of Xolloid, the
present results indicate that the Xolloid protease acts
through Chordin.
Xolloid Cleaves Chordin
To test whether Xolloid inactivates Chordin by proteoly-
sis, a biochemical approach was taken. Xolloid enzyme
was prepared by transfection of the 293T human kidney
cell line with a Xolloid construct tagged at its C terminus
with a Flag epitope. A day after transfection, the cells
were placed under serum-free conditions (in medium
containing Zn) for 48 hr. The conditioned medium con-
tained two bands in Western blots, a weak one of 150
kDa corresponding to the unprocessed proenzyme, and
a stronger band at 130 kDa, a size consistent with that
of the processed form lacking the amino-terminal prore-
gion (Figure 3A, lane 2). Processing is an absolute re-
quirement for the activity of astacin family zymogens
(Stocker et al., 1995). Conditioned medium from cells
transfected with DNA vector alone was used as a nega-
tive control throughout this study and found to be devoid
of activity (Figure 3, lane 1).
When the Xolloid enzyme was incubated with bacu-
lovirus-derived Chordin tagged in the carboxyl terminus
with Myc epitope (Piccolo et al., 1996),a cleavedproduct
was detected (Figure 3B, lane 2). To determine whether
this cleavage was caused by the secreted Xolloid en-
zyme, a range of protease inhibitors was added, and
only the Zinc chelator orthophenantroline was found to
be effective (Figure 3B, lanes 3 and 4). Furthermore,
we introduced a point mutation in the Xolloid protease
domain in a conserved tyrosine affected in the tolloid
antimorphic allele tld6P4 (Childs and O'Connor, 1994; Fi-
nelli et al., 1994). Structural studies in the Astacin family
of metalloproteases (reviewed by Stocker et al., 1995)
predict this residue to be dispensable for Zn binding
and folding of the protease domain, but crucial for its
catalytic activity. This protein, designated as dominant-
Figure 3. Xolloid Is a Secreted Protease That Cleaves Chordin Pro- negative XLD (DN-XLD) for its biological activities (see
tein at Two Specific Sites Figure 6 below), was secreted and processed (Figure
(A) Xolloid is secreted. Recombinant XLD was detected by an anti- 3A, lane 3) but was unable to cleave Chordin (Figure 3B,
Flag monoclonal antibody that recognizes an epitope tag placed at
the COOH terminiof XLD andof DN-XLD. Lane 1, control conditioned
medium (c.m.) from 293T cells transfected with vector DNA only;
lanes 2 and 3, equivalent aliquots of conditioned medium from Xld enzyme; lane 7, affinity-purified Xolloid-Flagprotein is able to cleave
and DN-Xld transfections, respectively. Note that processed Xolloid CHD.
protein of approximately 130 kDa is secreted into the medium; the (C±E) Mapping the Xolloid cleavage sites on Chordin. Chordin frag-
faint band at 150 kDa corresponds to the proenzyme. ments were visualized by (C) anti-NH2-CHD peptide, by (D) anti-
(B) Xolloid cleaves Chordin. Western blot analysis of CHD protein COOH-Myc, and by (E) anti-Internal-CHD (aI) antibodies. The re-
probed with an anti-Myc antibody that recognizes its COOH termi- sulting proteolytic fragments are indicated. (C±E) Lane 1, CHD is
nus. CHD protein was incubated for 10 hr as described in the Experi- full-length after incubation with control medium. Lane 2, Xolloid
mental Procedures with the following solutions: lane 1, control 293T cleaves CHD at two sites. Lane 3, before addition of Xolloid, CHD
conditioned medium is devoid of cleaving activity; lane 2, Xolloid- was preincubated for 2 hr at 258C with a 5 molar excess of recombi-
containing medium specifically cleaves CHD, removing an NH2-ter- nant human BMP-4, to cause the formation of CHD/BMP-4 com-
minal fragment; lane 3, Xolloid is inactivated by incubation with 1±10 plexes.
ortophenanthroline, an inhibitor of zinc metalloproteases; lane 4, (F) Noggin protein is not cleaved by Xolloid. Lanes 1, 2, and 3 are
Xolloid retains enzyme activity in the presence of a protease inhibitor Noggin in control medium, Noggin in Xolloid medium, and Xolloid
cocktail that does not affect metalloproteases but should block medium with Noggin-BMP-4 complexes, respectively.
serine, aspartic, and cysteine proteases (see Experimental Proce- Acrylamide percentages in the SDS±PAGE gels were as follow: (A)
dures for details); lane 5, the DN-Xld point mutation is catalytically and (B) 7%; (C) 6%±18% gradient; (D±F) 7.5%±18% gradient. For
inactive; lane 6, CHD-Myc protein used as substrate for purified samples in gel (E), the incubation time was extended to 16 hr.
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consistent with two cleavage sites, one occurring just
after the first cysteine-rich repeat (CR1), and another
located within CR3 (Figures 3C and 3D). The two cleav-
ages were confirmed by an internal anti-Chordin anti-
body (aI, newly derived here, see Experimental Pro-
cedures), which revealed that under more complete
digestion conditions, most of the Chordin protein re-
mained as an 85 kDa fragment lacking the amino- and
carboxy-terminal fragments (Figure 3E). Importantly,
Chordin precomplexed for 2 hr with a 2±10 molar excess
of BMP-4, in conditions in which all Chordin biological
activity is blocked (Piccolo et al., 1996), was an equally
good substrate for the Xolloid enzyme (Figures 3C±3E,
lane 3).
The Xolloid protease was completely inactive on a
HA-tagged noggin substrate (Figure 3F), in agreement
with the mRNA coinjection results (Figure 2E). We con-
clude that both Chordin and the Chordin/BMP complex
are cleaved by the Xolloid metalloprotease at two de-
fined sites.
Cleaved Chordin Protein Is Inactive
Having shown biochemically that Chordin is a substrate
for Xolloid, we next tested whether the cleavage inacti-
vated the biological activities of Chordin using ventral
marginal zone (VMZ) and animal cap explants. Chordin
protein (2 nM final concentration) was digested in vitro
with Xolloid conditioned medium to obtain nearly com-
plete cleavage. Untreated VMZ explants rounded up
forming ventral mesoderm, but elongated when treated
Figure 4. Cleavage of Chordin Causes Loss of Dorsalizing and BMP with control Chordin as a consequence of muscle induc-
Blocking Activity tion (Figures 4A and 4C). When Chordin predigested
(A±C) External views of ventral marginal zones (VMZs): (A) treated with Xolloid enzyme was used, the explants did not
with full-length CHD protein in control medium, (B) treated with XLD- elongate (Figure 4B) and failed to express the dorsal
cleaved Chordin protein, and (C) untreated VMZs. Note the lack of
mesoderm marker a-actin (Figure 4D). This shows thatelongation in (B).
dorsalization by Chordin is inactivated by cleavage with(D) Dorsal mesoderm is not induced in VMZs treated with digested
Xolloid.CHD. RT±PCR analysis was used to score for expression of the
muscle-specific marker a-actin in VMZs (n 5 20 per lane). EF1a Since Chordin should act by blocking BMP signaling,
(elongation factor 1a) provides a loading control. Note that digestion we next tested whether cleaved Chordin lost its ability
with Xolloid inactivates dorsalization by Chordin. to antagonize BMPs. Animal caps prepared at stage 8
(E) Cleaved CHD is unable to block the activity of BMP-4/7. Animal
were incubated until early gastrula (2±3 hr) with a Xeno-caps were dissected at blastula stage 8 and incubated with the
pus BMP-4/7 heterodimer that has an order of magni-indicated proteins until siblings reached stage 10Ã . Lane 1, untreated
tude more biological activity than BMP-4 homodimersanimal caps (AC). Lane 2, incubation in 0.7 nM BMP-4/7 induces
the ventral mesodermal marker Xhox3. Lanes 3±5, animal caps plus (Hazama et al., 1995; Suzuki et al., 1997). Xolloid condi-
0.7 nM BMP-4/7 preincubated for 2 hr at 258C with, respectively, tioned medium alone was devoid of activity in this assay
CHD, CHD cleaved by XLD, and CHD incubated in control medium. (data not shown). Addition of 0.7 nM BMP-4/7 activated
Note that Chordin preincubated with Xolloid is unable to block BMP
the ventral marker Xhox3, and 1 nM Chordin preventedsignaling.
this activation (Figure 4E, lanes 2 and 3). However, the
same concentration of cleaved Chordin had lost its abil-
lane 5). In addition, purified Xolloid enzyme prepared by ity to antagonize BMP-4/7 (Figure 4E, lane 4). The results
Flag antibody affinity matrix was found to be active on indicate that the cleavage by Xolloid inactivates the anti-
Chordin substrate (Figure 3B, lanes 6 and 7). These BMP activity of Chordin.
experiments suggest that the cleavage of Chordin is
mediated by the Xolloid enzyme and not by other com- Xolloid Releases Active BMP from
ponents present in the conditioned medium. Chordin/BMP Complexes
To map the sites at which Chordin is cleaved by Xol- To test whether Xolloid digestion is able to release active
loid, we analyzed the digestion products with three dif- BMPs from inactive Chordin/BMP complexes, we used
ferent antibodies. An anti-amino peptide antibody (Pic- an established assay for BMP activity. This assay is very
colo et al., 1996) detected, in addition to the undigested sensitive, permitting detection of BMP activity in the
120 kDa Chordin band, two bands of 19.5 and 102 kDa subnanomolar range, at levels lower than those of any
(Figure 3C), while the carboxy-terminal Myc tag identi- current biochemical method.Wilsonand Hemmati-Brivan-
fied two bands of 96 and 16 kDa (Figure 3D). These lou (1995) found that BMP-4 is able to prevent the auto-
neuralization caused by dispersal of the inner layer of thedata with antibodies specific for the two termini are
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a residue that is conserved in the Xolloid protein (Figure
6A). The same Tyr-to-Asn point mutation was introduced
in Xolloid. The mutant protein was processed and se-
creted normally (Figure 3A, lane 3) butwas enzymatically
inactive on its Chordin substrate (Figure 3B, lane 5).
Radial injection at the 4-cell stage of mRNA encoding
this point mutation (DN-Xld) resulted in dorsalized em-
bryos with enlarged heads and cement glands (Figure
6D), whereas wild-type Xld had ventralizing activity (Fig-
ure 6C). The dorsalization caused by DN-Xld affected
patterning of the ectodermal and mesodermal germ lay-
ers, expanding and increasing the intensity of expres-
sion of Sox-2 (neural plate), chordin (organizer and noto-
chord), and MyoD (somitic muscle) markers (Figures
6E±6G), as expectedfrom increased Spemann organizer
activity.
To demonstrate that DN-Xld can indeed antagonize
the activity of wild-type Xld, coinjection and biochemical
experiments were carried out. Injection of XLD mRNA
into dorsal blastomeres caused ventralization with re-
duction of head structures (Figure 6H), which was res-
cued by coinjection with a 4-fold excess of DN-Xld (Fig-
ure 6I). For biochemical tests, DN-Xld was cotransfected
with Xld into 293T cells and the conditioned medium
tested for Chordin cleaving activity. The samplecotrans-
fected with DN-Xld had much reduced enzyme activ-
ity when compared to Xolloid alone, although similar
amounts of wild-type Xolloid, marked by a HA-epitope
tag, were present in both samples (Figure 6J and data
Figure 5. Xolloid Digestion Causes the Release of Biologically Ac- not shown). These studies with DN-Xld suggest that
tive BMP-4/7 from Inactive CHD/BMP Complexes the endogenous Xolloid product is required to limit the
Top: experimental design. Bottom: RT±PCR of dissociated-reaggre- extent of the Chordin field of activity in vivo.
gated animal cap cells. N-CAM is used as a pan neural marker,
keratin as an epidermal-specific marker, XBRA as a mesodermal
marker, and EF1a as a loading control. Lane 1, stage 18 whole
Discussionembryos. Lanes 2 and 3, autoneuralization, denoted by the high
NCAM and low keratin band intensities, caused by cell dispersal in,
respectively, uninjected and Xld-injected animal caps.Lane 4, BMP- Chordin Is a Substrate for Xolloid
4/7 protein (0.7 nM) induces epidermis and suppresses neural induc- Xolloid is a gene expressed uniformly inunfertilized eggs
tion. Lane 5, BMP signaling is blocked by preincubation of BMP- and during early embryogenesis through late gastrula
4/7 with Chordin (1 nM). Lane 6, injection of XLD mRNA into animal
stages, and its mRNA is a ventralizing agent that mimicscap cells at the 8-cell stage causes release of active BMP-4/7 from
the effects of injection of low doses of BMP-4 (Goodmanthe previously inactive complex (compare to lane 5).
et al., 1997 and Figure 1). Microinjection of DNBMPR
showed that an active BMP pathway is required for
ventralization by Xolloid mRNA. The known dorsalizinganimal cap. Furthermore, BMP-4 acts as an epidermal
(keratin) inducer in this assay. In our experiments, addi- factors that work by inhibiting BMPs, Chordin, Noggin,
and Follistatin, were tested in coinjection experiments,tion of 0.7 nM BMP-4/7 was sufficient to prevent auto-
neuralization and to induce keratin in dispersed animal and Xolloid was found to specifically block the activity of
Chordin. Biochemical analyses using Xenopus proteinscap cells (Figure 5, lane 4). These activities were blocked
by preincubating BMP-4/7 with 1 nM Chordin (Figure 5, showed that Chordin, but not Noggin, was a substrate
for the Xolloid zinc metalloprotease. Xolloid cleavedlane 5). However, when the animal caps were isolated
from embryos injected into the animal pole with Xolloid Chordin at two sites, one located just after CR1 and
the other within CR3. These cleavages inactivate themRNA, BMP activity was restored from the previously
inactive Chordin/BMP complex, repressing neural tissue biological activity of Chordin, indicating that Xolloid acts
through Chordin. It should be noted, however, that ourand inducing keratin (Figure 5, lane 6). Thus, Xolloid is
able to release active BMP by proteolytic digestion of data do not exclude that Xolloid could have additional,
as yet undiscovered, substrates.the Chordin substrate.
In a companion study, MarqueÂ s et al. (1997 [this issue
of Cell, 417±426]) show that Drosophila tolloid mRNADominant-Negative Xolloid Dorsalizes
Ectoderm and Mesoderm inhibits chordin, but not noggin, activity in Xenopus em-
bryos. In transient transfection experiments, DrosophilaTo test the in vivo function of Xolloid protein in Xenopus,
we constructed a dominant-negative enzyme. A strong SOG was cleaved at three specific sites by Tolloid, and
two of these sites mapped to regions similar to thosetolloid antimorphic allele, called tld6P4, mapped to tyro-
sine 272 (Childs and O'Connor, 1994; Finelli et al., 1994), described for Xenopus Chordin and Xolloid in this study.
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Cleavage of SOG by Tolloid was stimulated by DPP
(MarqueÂ s et al., 1997), whereas Chordin digestion by
Xolloid was equally active when Chordin alone or
Chordin/BMP-4 complex was offered as substrate. The
cause of the BMP stimulation difference is unknown,
but could be due to biochemical assay conditions, to
the properties of the protease, to the folding of Sog and
Chordin substrates when complexed with BMPs, or to
additional protein factors present in Drosophila cultured
cells. However, it is clear that Xolloid can cleave Chor-
din/BMP complexes effectively.
By using a sensitive dissociation/reaggregation ani-
mal cap assay, we were able to show that cleavage by
Xolloid of an inactive Chordin/BMP-4/7 complex results
in the release of BMP antineuralizing and epidermis-
inducing activity (Figure 5). The digestion of Chordin/
BMP complexes by a metalloprotease provides a novel
mechanism by which a latent growth factor, rendered
inactive by binding to an extracellular antagonist, can
be reactivated at particular locations. If the Chordin/
BMP complex were diffusible, this mechanism could
facilitate the transport and redistribution of BMPs as
has been proposed for SOG/DPP (Holley et al., 1996).
In Drosophila, it is clear that the sog product must be
diffusible over long distances, because mosaic studies
have shown that sog is required in ventral ectoderm for
the formation of the dorsal-most tissue (Zusman et al.,
1988). The biochemical and biological data show that
Xolloid can proteolytically inactivate Chordin; thus, the
ventralization caused by Xolloid seems to act through
a double inhibition mechanism involving Chordin:
XLD ¢ CHD ¢ BMPs → BMPR
Xolloid Is Required for D-V Patterning
A dominant-negative Xolloid (DN-Xld) was generated
by introducing a point mutation previously identified
in a Drosophila tolloid antimorphic allele (Childs and
O'Connor, 1994; Finelli et al., 1994), and overexpression
throughout the embryo resulted in expanded dorsal
structures in both ectoderm and mesoderm. This rever-
sal of the Xolloid mRNA ventralizing phenotype by a
dominant-negative construct suggests that the normalFigure 6. In Vivo Role of Xolloid: Expansion of Organizer Activity in
function of Xolloid in Xenopus development is to limitEmbryos Injected with Dominant-Negative Xolloid
the expansion of Spemann's organizer field. DN-Xolloid(A) Top, schematic structure of Xolloid: EGF and C1r/s are protein±
retains a wild-type interaction domain but its proteaseprotein interaction domains. Bottom, sequence of the protease do-
main of Drosophila Tolloid and of Xenopus Xolloid surrounding a domain is catalytically inactive on Chordin substrate.
conserved tyrosine (circled, position 272 in Tolloid and 296 in Xol- In view of the present results, it appears that inacti-
loid) mutated in DN-Xld. vating the catalytic activity is sufficient to block the
(B) Control stage 29 embryo. activity of the wild-type enzyme. In principle, mutations
(C) Xld gain-of-function: ventralized embryo injected with 200 pg of
similar to the one introduced here could be used as aXLD mRNA in each blastomere at the 4-cell stage.
general method to block the function of most members(D) Dorsalization in embryos similarly injected with 300 pg of DN-
XLD mRNA (76%, n 5 127). Compare with sibling embryo in (B); the of the growing family of zinc metalloproteases (Stocker
head and cement gland are enlarged, reflecting dorsalization of the et al., 1995) in vivo.
embryos. An inversion of the dorsoventral axis has occurred
(E±G) In situ hybridization for the indicated markers in control (left)
during evolution, but the molecular mechanisms of pat-or DN-XLD mRNA±injected (right) embryos. The neural domain
terning by the DPP/BMP and SOG/CHD extracellularmarked by Sox-2 (E) and the dorsal mesoderm domains marked by
Chd (F) or MyoD (G) are expanded and increased in intensity in DN-
Xld-injected embryos (n 5 24, 10, and 15, respectively), indicating
increased organizer activity. The injected embryo in (E) is shortened (200 pg) and DN-XLD mRNA (800 pg). This indicates that DN-Xld
due to dorsalization. can antagonize wild-type Xld.
(H) Stage 20 embryos injected in the two dorsal blastomeres at the (J) Western blot showing that DN-Xld protein produced by cotrans-
8-cell stage with 200 pg of Xolloid mRNA. fection inhibits the enzymatic activity of Xolloid on Chordin sub-
(I) Normal development is restored by coexpression of XLD mRNA strate.
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In Situ Hybridization and RT±PCRproteins has been conserved (Holley et al., 1995; De
Whole-mount in situ hybridizations were carried out according toRobertis and Sasai, 1996). Our results suggest that an
Harland's method (Harland, 1991) with minor modifications. Theadditional component of this regulatory cascade, a zinc
activities of CHD and BMP proteins (Figures 4 and 5) were assayed
metalloprotease, has also been conserved. A point mu- by RT±PCR, using conditions and primers previously described in
tation identified in the original Heidelberg screen for Sasai et al. (1995) for testing CHD activity, in Suzuki et al. (1997) for
Xhox3, and inWilson and Hemmati-Brivanlou (1995) for the dissocia-zygotic mutations in the third chromosome of Drosoph-
tion-reaggregation experiments.ila (JuÈ rgens et al., 1984) permitted the construction of
the dominant-negative form of Xolloid used in this study.
Protein Expression and PurificationIt is remarkable that the mechanisms of dorsoventral
293T cells (70% confluency) were transfected by CaPO4 with Xld,
development have been conserved to such an extent DN-Xld, and noggin cDNAs in pcDNA 3.1 (15 mg per 10 cm Petri
that one can design dominant-negative mutations based dish) in DMEM-10% fetal calf serum. 24 hr after transfection, a
subconfluent cell monolayer was washed three times with Hank'son information from Drosophila, an organism that di-
balanced salt solution and cultured in serum-free medium for 48verged from a common Urbilaterian ancestor 500 million
hr. Optimal expression was observed using a mixture of DMEM,years ago.
H12, and Iscoves media (33% each). H12 was included because
Dorsoventral patterning of the embryo is mediated by it contains zinc. Proteins secreted by 293T cells transfected with
the graded activity of DPP in Drosophila and of BMP-4/2 pcDNA3.1 only and cultured in the same way were used as negative
in vertebrates (Ferguson and Anderson, 1992b; Dosch control throughout this study. The conditioned media were clarified
by low- and high-speed centrifugation and, after addition of 2.5et al., 1997). However, the transcripts of these genes
mM CaCl2, concentrated to 10% its original volume with Centriplusare not expressed in graded fashion (Ferguson and An-
(Amicon). Concentrated media were then dialyzed against 10 mMderson, 1992b; Wharton et al., 1993; Fainsod et al., 1994;
HEPES (pH 7.6), 150 mM NaCl, 2.5 mM CaCl2, 1 mM MgCl2, and 1Hemmati-Brivanlou and Thomsen, 1995). Work from
mM ZnCl2 (buffer A). Aliquots were snap-frozen and stored at 2808C.
Drosophila suggests that the gradient of DPP activity During this study, we used different preparations of Xolloid (n 5 4),
control (n 5 3), and DN-Xld (n 5 2) proteins with similar results.results in part from the diffusion of SOG (Biehs et al.,
For affinity purification of Xolloid-Flag (Figure 3B, lane 7), 10 ml1996; Holley et al., 1996). It isnot knownwhether Chordin
of Xld-Flag conditioned medium received NaCl to 0.5 M and of Brij35is diffusible in Xenopus, but in view of the patterning
to 0.2% final concentrations and was then subjected to affinity
defects observed in the chordino mutation in zebrafish purification using a Flag affinity matrix (IBI). Binding was for 2 hr in
(Hammerschmidt et al., 1996b; Schulte-Merker et al., batch; washings were in a column with 10 mM HEPES (pH 7.6), 0.5
1997), this remains a distinct possibility. The present M NaCl, and 0.2% Brij35 followed by buffer A. Elution was with Flag
peptide (IBI) in buffer A. Fractions were identified by Western blotstudy suggests the existence of an additional layer of
and silver staining and frozen.regulation of Chordin function. We propose that the Xol-
CHD protein was obtained from baculovirus as described (Piccololoid protease may act as a clearing system for Chordin.
et al., 1996). For digestion, we incubated 5 ng of CHD-Myc protein
Whereas BMP-4 can be constantly removed by interac- with 7.5 ml of Xolloid-Flag (about 1 ng), DN-Xld-Flag, or control
tions with its receptor, such a mechanism is not available medium for 10 hr at 308C. When a more complete digestion was
for Chordin, which lacks a receptor. In this view, the required in experiments assaying the activity of cleaved CHD (Figure
4), 15 ml of enzyme and 16 hr of incubation were used. Some offunction of the Xolloid protease might be to provide a
our preparations of baculovirus CHD-Myc had degraded C terminimolecular sink required to maintaina gradient of Chordin
lacking C3 and C4, giving low molecular weight fragments positivedorsalizing activity emanating from Spemann's orga-
for the anti-Myc antibody. To overcome this background problem,
nizer. for the anti-Myc Western blotting of Figure 3C we used a full-length
CHD protein purified by cation exchange chromatography. Briefly,
cleared baculovirus medium was loaded in a High S column (Bio-
Experimental Procedures Rad), washed with 10 mM HEPES (pH 7.6), NaCl 80 mM, and proteins
eluted with a linear gradient of 80±1200 mM NaCl in 10 mM HEPES
Expression Constructs and Synthetic mRNA Preparation (pH 7.6). Full-length undegraded Chordin eluted around 0.8 M NaCl.
Full-length Xld DNA (GenBank accession number Y09660) was ex- For protease inhibition studies, we used 1 mM 1±10 orthophenan-
cised with EcoRI±DraIII and subcloned in the EcoRI±StuI sites of throline (a Zn metalloprotease inhibitor) and a cocktail of 1 mM
pCS2 to generate pCS2-Xld. A Flag-tagged version of Xld was de- PMSF, 10 mM Pepstatin, and 1 mM E64 that inhibit, respectively,
rived by PCR by inserting the sequence DYKDDDDK-Stop after the serine, aspartic, and cysteine proteases.
last amino acid of Xolloid. mRNA prepared from the resulting plas-
mid (pCS2-Xld-Flag) had indistinguishable activity from Xld mRNA Antibodies and Western Blotting
lacking the tag (ventralization 88%, n 5 52). Xld-HA was derived For Western blotting, protein samples were resolved under reducing
by a similar procedure. Dominant-negative Xld contains a point conditions by SDS±PAGE and electroblotted onto Immobilon P
mutation (TAT into AAT) of Tyr-296 into Asn, introduced by a PCR- (Millipore) PVDF membranes. The filters were blocked with 5% pow-
based approach. After checking the presence of the mutation and dered Carnation milk in TBST and incubated in the same buffer with
the fidelity of the amplified DNA by sequencing, a point-mutated 59 a 1:500 dilution of all antibodies except for the anti-Internal-CHD
EcoRI±SphI fragment was ligated to a wild-type SphI±XbaI Xld-Flag antibody, for which a 1:3000 dilution was used. The ECL lumines-
fragment intopCS2 to generate pCS2-DN-Xld. For transfection stud- cence detection kit was from Amersham. Detection of the various
ies, Xld-Flag and DN-Xld-Flag sequences were subcloned in the epitope tags was carried out with the following mouse monoclonal
EcoRI±XbaI sites of pcDNA3.1. HA-tagged noggin (pcDNA3.1 nog- antibodies: anti-myc (Babco), anti-Flag M2 (IBI), and anti-HA
gin) was generated by PCR, incorporating the sequence YPYDVP- (Babco). Anti-NH2 CHD peptide antibody was produced as de-
DYA-Stop after the last amino acid of noggin. All of these PCR scribed (Piccolo et al., 1996). For obtaining an anti-Internal-CHD
reactions were done with Pfu polymerase (Stratagene) that contains antibody, a CHD peptide (coding from amino acid 592 to 692) was
proofreading activity. expressed in bacteria as a GST fusion protein, purified in a glutathi-
Synthetic mRNA was prepared using the Message Machine in one column (Pharmacia), and injected into rabbits (Babco).
vitro transcription kit (Ambion). For sense mRNAs, pCS2-Xld and
pCS2-DN-Xld were linearized with NotI and transcribed with SP6. Embryological Manipulations
DNBMPR, noggin, and follistatin mRNA were synthesized as de- Ventral marginal zone explants (comprising 608 of the VMZ) from
stage 10 embryos were prepared in LCMR, opened with an eyebrowscribed in Sasai et al. (1995).
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knife, and immediately transferred to LCMR containing Xolloid or Goodman, S., Albano, R., Wardle, F., Matthews, G.,Tannahill, D., and
Dale, L. (1997). BMP1-related proteins promote the development ofcontrol digested CHD protein. 96-well PCR plates (Costar) treated
ventral mesoderm in early Xenopus embryos. Dev. Biol., in press.with 5% PolyHEMA (Polysciences) were used, and a single explant
was put in each well containing 20 ml of solution. After overnight Graff, J.M. (1997). Embryonic patterning: to BMP or not to BMP,
incubation at 208C, the explants were transferred to 0.4 3 MMR. In that is the question. Cell 89, 171±174.
experiments testing the activity of BMP-4/7, intact caps were ex- Graff, J.M., Scott Thies, R., Song, J.J., Celeste, A.J., and Melton,
cised at stage 8 and kept open using VLCMR (Piccolo et al., 1996). D.A. (1994). Studies with a Xenopus BMP receptor suggest that
The explants were incubated in BMP-4/7 protein or CHD/BMP-4/7 ventral mesoderm-inducing signals override dorsal signals in vivo.
complexes until siblings reached stage 10 1/2. To test whether Xol- Cell 79, 169±179.
loid proteolytic activity releases active BMP-4/7 from inactive com-
Hammerschmidt, M., Pelegri, F., Mullins, M.C., Kane, D.A., vanplexes with CHD, stage 8 animal caps weredissociated as described
Eeden, F.J.M., Granato, M., Brand, M., Furutani-Seiki, M., Haffter,in Wilson and Hemmati-Brivanlou (1995). For each point, cells from
P., Heisenberg, C.-P., et al. (1996a). dino and mercedes, two genes15 animal caps from wild-type or from embryos injected with 250
regulating dorsal development in the zebrafish embryo. Develop-
pg/blastomere XLD mRNA in the animal pole were used in a final
ment 123, 95±102.
volume of 70 ml. After 4 hr, cells were reaggregated by addition of
Hammerschmidt, M., Serbedzija, G.N., and McMahon, A.P. (1996b).70 ml of 1.4 3 MMR and cultured to stage 18. All explant experiments
Genetic analysis of dorsoventral pattern formation in the zebrafish:were performed 2±3 times with similar results.
requirement of a BMP-like ventralizing activity and its dorsal repres-
sor. Genes Dev. 10, 2452±2461.Acknowledgments
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